These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 9245700

  • 1. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice.
    Keidar S, Attias J, Smith J, Breslow JL, Hayek T.
    Biochem Biophys Res Commun; 1997 Jul 30; 236(3):622-5. PubMed ID: 9245700
    [Abstract] [Full Text] [Related]

  • 2. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
    Hayek T, Attias J, Coleman R, Brodsky S, Smith J, Breslow JL, Keidar S.
    Cardiovasc Res; 1999 Dec 30; 44(3):579-87. PubMed ID: 10690290
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, Aviram M.
    Circulation; 2004 May 11; 109(18):2213-20. PubMed ID: 15123520
    [Abstract] [Full Text] [Related]

  • 5. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.
    Hayek T, Attias J, Smith J, Breslow JL, Keidar S.
    J Cardiovasc Pharmacol; 1998 Apr 11; 31(4):540-4. PubMed ID: 9554802
    [Abstract] [Full Text] [Related]

  • 6. Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages.
    Keidar S, Heinrich R, Kaplan M, Aviram M.
    J Renin Angiotensin Aldosterone Syst; 2002 Mar 11; 3(1):24-30. PubMed ID: 11984744
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antagonists of angiotensin II receptor].
    Karasek D, Adamski M, Grzeszczak W.
    Postepy Hig Med Dosw; 1996 Mar 11; 50(1):21-32. PubMed ID: 8778711
    [Abstract] [Full Text] [Related]

  • 9. Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production.
    Shimada K, Murayama T, Yokode M, Kita T, Fujita M, Kishimoto C.
    Nutr Metab Cardiovasc Dis; 2011 Sep 11; 21(9):672-8. PubMed ID: 20399087
    [Abstract] [Full Text] [Related]

  • 10. Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients.
    Hayek T, Aviram M, Heinrich R, Sakhnini E, Keidar S.
    Biochem Biophys Res Commun; 2000 Jul 05; 273(2):417-20. PubMed ID: 10873620
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
    Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB.
    Arterioscler Thromb Vasc Biol; 2007 May 05; 27(5):1080-6. PubMed ID: 17347482
    [Abstract] [Full Text] [Related]

  • 12. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.
    Circulation; 2003 Apr 01; 107(12):1640-6. PubMed ID: 12668499
    [Abstract] [Full Text] [Related]

  • 13. Chronic effect of losartan in a murine model of dilated cardiomyopathy: comparison with captopril.
    Kanda T, Araki M, Nakano M, Imai S, Suzuki T, Murata K, Kobayashi I.
    J Pharmacol Exp Ther; 1995 May 01; 273(2):955-8. PubMed ID: 7752100
    [Abstract] [Full Text] [Related]

  • 14. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN.
    J Clin Invest; 1998 Apr 15; 101(8):1581-90. PubMed ID: 9541487
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin.
    Keidar S, Attias J, Coleman R, Wirth K, Schölkens B, Hayek T.
    J Cardiovasc Pharmacol; 2000 Jan 15; 35(1):64-72. PubMed ID: 10630734
    [Abstract] [Full Text] [Related]

  • 16. Losartan (Cozaar).
    Baldinger S.
    Conn Med; 1996 May 15; 60(5):281-4. PubMed ID: 8998906
    [No Abstract] [Full Text] [Related]

  • 17. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, Hasegawa Y, Kaneko K, Ogihara T, Ishihara H, Sato Y, Takikawa K, Nishimichi N, Matsuda H, Sawamura T, Oka Y.
    Circulation; 2008 Jul 01; 118(1):75-83. PubMed ID: 18559699
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice.
    Zhou Y, Chen R, Catanzaro SE, Hu L, Dansky HM, Catanzaro DF.
    Am J Hypertens; 2005 Apr 01; 18(4 Pt 1):486-92. PubMed ID: 15831357
    [Abstract] [Full Text] [Related]

  • 19. Serotonin derivatives, major safflower (Carthamus tinctorius L.) seed antioxidants, inhibit low-density lipoprotein (LDL) oxidation and atherosclerosis in apolipoprotein E-deficient mice.
    Koyama N, Kuribayashi K, Seki T, Kobayashi K, Furuhata Y, Suzuki K, Arisaka H, Nakano T, Amino Y, Ishii K.
    J Agric Food Chem; 2006 Jul 12; 54(14):4970-6. PubMed ID: 16819904
    [Abstract] [Full Text] [Related]

  • 20. A new antihypertensive class: the angiotensin receptor antagonist.
    Kupecz D.
    Nurse Pract; 1996 Mar 12; 21(3):106, 109, 113-4. PubMed ID: 8710244
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.